MAKE WAY FOR THE FIRST ACTIVE HEMOSTATIC POWDER

MAKE WAY FOR THE FIRST ACTIVE HEMOSTATIC POWDER

09 NOVEMBER 2017

Biom’up confirms the success of its IPO

Reinforcement of shareholders’ equity of €60 million through the initial public offering of witch: – around €42.5 million within the frame of the offer – €17.3 million in bonds capitalization
Implementation of a liquidity contract with CM-CIC Market Solutions

Read more:

pr-09-11-17

ALL NEWS

Legal Information: HEMOBLAST™ Bellows - Implantable Medical device Class III for surgery reserved for use by qualified healthcare professionals, reimbursement depends on each country.
Read the instructions for use on the packaging carefully before use. CE0086: BSI - Manufacturer: Biom’up SA France.